Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01761357
Other study ID # RC12_0387
Secondary ID
Status Completed
Phase N/A
First received January 3, 2013
Last updated September 22, 2015
Start date January 2013
Est. completion date December 2014

Study information

Verified date September 2015
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority France: Committee for the Protection of Personnes
Study type Interventional

Clinical Trial Summary

The aim of the study is to determine whether the burden of comorbidities measured by CIRS-G (Cumulative Illness Rate Scale) is associated with a non-amelioration of the health related quality of life measured by questionnaire called "SF-36", six months after a transcatheter aortic valve replacement in older patients. During the comprehensive geriatric assessment realized before the valve implantation, the following data are recorded and their impact of the health related quality of life will also be analysed: comorbidity, age, depression, functional status, the cognitive impairment and malnutrition.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 75 Years and older
Eligibility Inclusion Criteria:

- Patients aged 75 years and older

- Patients referred for a transcatheter aortic valve implantation

- Patients who have a comprehensive geriatric assessment realized during the three months before the valve implantation

- Patients who provide informed written consent

Exclusion Criteria:

- Patients who refuse the study

- Patients with a legal guardian

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Other:
answering to questionnaires of quality of live


Locations

Country Name City State
France Angers Universitary Hospital Angers
France Nantes Universitary Hospital Nantes

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference of the physical component summary score of the health survey scale called "SF36", between inclusion and one month after the valve implantation. 1 month No
Secondary Difference of the physical component summary score of the health survey scale called "SF36", between inclusion and three months after the valve implantation. three months No
Secondary Difference of the physical component summary score of the health survey scale called "SF36", between inclusion and six months after the valve implantation. six months No
Secondary Difference of the score of the Instrumental Activities of Daily Living scale called "IADL", between inclusion and one month after the valve implantation. one month No
Secondary Difference of the score of the Instrumental Activities of Daily Living scale called "IADL", between inclusion and three months after the valve implantation. three months No
Secondary Difference of the score of the Instrumental Activities of Daily Living scale called "IADL", between inclusion and six months after the valve implantation. six months No
Secondary Difference of the score of the Geriatric Depression Scale (GDS), between inclusion and one month after the valve implantation. one month No
Secondary Difference of the score of the Geriatric Depression Scale called "GDS", between inclusion and three months after the valve implantation three months No
Secondary Difference of the score of the Geriatric Depression Scale scale called "GDS", between inclusion and six months after the valve implantation six months No
Secondary Complications during the six months of follow up with all causes of mortality 6 months No